Navigation Links
Baron & Budd Supports Encouraging New Development in Mesothelioma Treatment
Date:11/15/2013

LOS ANGELES (PRWEB) November 15, 2013

Mesothelioma survival rates may be substantially improved through increased use of a certain form of chemotherapy, researchers at the Moffit Cancer Center and Research Institute at the University of South Florida recently announced. Patients undergoing this repeated treatment, according to the researchers, not only live longer but also have a better quality of life.

The announcement was the result of a lengthy study of peritoneal mesothelioma patients between June of 2004 and March of 2012. Researchers reported that those who underwent a second treatment of heated intraperitoneal chemotherapy, or HIPEC, survived more than three times longer than those who had only one round. The findings were recently published in the Annals of Surgical Oncology.
(http://www.annsurgoncol.org/journals/abstract.html?v=0&j=10434&i=0&a=3341_10.1245_s10434-013-3341-7&doi=)

The HIPEC procedure is performed as soon as possible after a surgery in order to reduce the number of tumor cells in a patient. After a tumor has been removed, a solution containing various chemotherapeutic agents is heated to 106 degrees Fahrenheit. This solution is circulated through a patient’s abdominal cavity at a very precise rate for two hours. The treatment has been proven effective at reducing patient discomfort and killing the cancerous cells.

“We are continually encouraged by the commitment and excellence of the bright minds that are working to fight this terrible disease,” said Russell Budd, managing director of mesothelioma law firm Baron & Budd. “We applaud the work of the Moffit Cancer Center researchers, as well as all that of the other professionals who tirelessly work for a cure.”

If you would like to learn more about what to do if you or a loved one has been diagnosed with mesothelioma, please call Baron & Budd at 1-866-855-1229. Baron & Budd is a sponsor of CURE Media Group's informative book, Understanding Mesothelioma.

About Baron & Budd, P.C.

The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of “Protecting What’s Right” for asbestos sufferers and their families. As one of the first law firms to successfully litigate an asbestos lawsuit, Baron & Budd continues to actively represent veterans, industry workers and others who are suffering as a result of exposure to asbestos. Baron & Budd achieved the largest mesothelioma verdict ever in the state of Texas, a $55 million verdict for an asbestos sufferer and his family in El Paso, Texas. Contact Baron and Budd at 1.866.855.1229 for additional information on mesothelioma treatments, mesothelioma cancer doctors and treatment centers and mesothelioma attorneys.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11334903.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
4. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
5. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
6. Baron and Budd is Encouraged by the First Federal Transvaginal Mesh Lawsuit Verdict
7. Baron and Budd Announces Second Transvaginal Mesh Lawsuit Settlement for Bard
8. Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo
9. Mesothelioma Law Firm Baron & Budd Calls Attention to Veterans Suffering from Asbestos-Related Diseases
10. Research shows efficacy of treatment model developed at Women & Infants
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy of ... and tech within the industry, from leading advocates, associations and industry leaders such ...
(Date:5/27/2016)... ... 2016 , ... Beleza Medspa has initiated a new program to ... the first time that Coolsculpting is being used for for more than just cosmetic ... they meet the prescribed body-fat standard, measured by the circumference-based tape method. The ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/27/2016)... ... , ... With a team of certified experts, Validation Center ... its GMP accreditation, Validation Center is also a registered authority of the international ... , Validation Center is ISO17025 accredited and only offers its clients the latest ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Digital Health Dialog, LLC dba EngagedMedia ... US Patent and Trademark Office of U.S. Patent ... for electronic opt-­in and processing of discount coupons ... compliance and otherwise. Logo - http://photos.prnewswire.com/prnh/20160524/371583LOGO ... "Our technology allows for individuals to opt­-in to ...
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
Breaking Medicine Technology: